Clinical Trial: A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic Acids NKS-3 and NKS-5

U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07924267) titled 'A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic Acids NKS-3 and NKS-5' on Oct. 27.

Brief Summary: This study is designed as a single ascending dose and multiple ascending dose single-blind, placebo controlled, randomized, monocentric trial. 60 obese men and women will be recruited for single ascending dose (Groups 1,2,3), according to the following inclusion and non-inclusion criteria.

60 obese men and women will be recruited for multiple ascending doses (Groups 4,5,6), according to the following inclusion and non-inclusion criteria.

Study Star...